First Time Loading...

F-Star Therapeutics Inc
NASDAQ:FSTX

Watchlist Manager
F-Star Therapeutics Inc Logo
F-Star Therapeutics Inc
NASDAQ:FSTX
Watchlist
Price: 7.12 USD Market Closed
Updated: Jun 1, 2024

F-Star Therapeutics Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

F-Star Therapeutics Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
F-Star Therapeutics Inc
NASDAQ:FSTX
Other Liabilities
$4.4m
CAGR 3-Years
-20%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.8B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$3.4B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
24%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$6.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
23%
CAGR 5-Years
51%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.1B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
18%

See Also

What is F-Star Therapeutics Inc's Other Liabilities?
Other Liabilities
4.4m USD

Based on the financial report for Dec 31, 2021, F-Star Therapeutics Inc's Other Liabilities amounts to 4.4m USD.

What is F-Star Therapeutics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-7%

Over the last year, the Other Liabilities growth was 44%. The average annual Other Liabilities growth rates for F-Star Therapeutics Inc have been -20% over the past three years , -7% over the past five years .